MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
1.580
+0.020
+1.28%
After Hours: 1.645 +0.065 +4.11% 19:41 04/07 EDT
OPEN
1.500
PREV CLOSE
1.560
HIGH
1.615
LOW
1.440
VOLUME
1.28M
TURNOVER
--
52 WEEK HIGH
13.44
52 WEEK LOW
1.440
MARKET CAP
57.93M
P/E (TTM)
-0.4001
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INO last week (0331-0404)?
Weekly Report · 19h ago
Inovio Pharmaceuticals Inc. Stock Rallies 10.7%, Outperforms Competitors
Dow Jones · 5d ago
Inovio Pharmaceuticals Inc. Stock Slips 5.8%, Underperforms Competitors
Dow Jones · 03/31 20:33
Weekly Report: what happened at INO last week (0324-0328)?
Weekly Report · 03/31 09:29
Inovio Pharmaceuticals Inc. Stock Sheds 3.7%, Underperforms Competitors
Dow Jones · 03/25 20:34
Weekly Report: what happened at INO last week (0317-0321)?
Weekly Report · 03/24 09:26
Inovio Pharmaceuticals’ Earnings Call: Progress Amid Challenges
TipRanks · 03/22 00:04
Biotech Alert: Searches spiking for these stocks today
TipRanks · 03/21 16:00
More
About INO
More
Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from human papillomavirus (HPV)-related diseases, cancer, and infectious diseases. Its proprietary investigational CELLECTRA devices are designed to deliver the plasmids into the body’s cells for optimal effect, without the use of chemical adjuvants, lipid nanoparticles or viral vectors. Its lead candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease caused by HPV-6 and HPV-11. Its DNA medicines in the pipeline include INO-3112 for the Treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, VGX-3100 for the Treatment of HPV-related Cervical HSIL, VGX-3100 for the Treatment of Anal or Perianal HSIL, INO-5401 for the Treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Prevention of Cancer for People with BRCA1/2 Mutation.
Recently
Symbol
Price
%Change

Webull offers Inovio Pharmaceuticals Inc stock information, including NASDAQ: INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.